LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

Search

Amicus Therapeutics Inc

Closed

Sector Healthcare

10.99 0.73

Overview

Share price change

24h

Current

Min

10.89

Max

11.14

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+67.64 upside

News Sentiment

By Acuity

50%

50%

122 / 366 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Amicus Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

19 wrz 2024, 23:50 UTC

Hot Stocks

Stocks to Watch: Nike, FedEx, Alliance Entertainment Holding, Arq

19 wrz 2024, 20:59 UTC

Earnings

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q -- Update

19 wrz 2024, 20:41 UTC

Top News

Nike CEO John Donahoe to Retire

19 wrz 2024, 20:40 UTC

Earnings

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q

19 wrz 2024, 23:24 UTC

Market Talk

Sims U.S. Business Shines, But Asia Headwinds Remain -- Market Talk

19 wrz 2024, 23:01 UTC

Top News

U.K. Consumers Turn Notably Gloomier, Survey Says

19 wrz 2024, 22:21 UTC

Market Talk
Earnings

FedEx Warns of Continued, Worsening Headwinds in 2Q -- Market Talk

19 wrz 2024, 22:17 UTC

Top News

Why Fed Rate Cuts Are Hurting Treasury Bonds -- Barrons.com

19 wrz 2024, 22:13 UTC

Market Talk
Earnings

FedEx Counts on Price Hikes to Help Hurting Top and Bottom Lines -- Market Talk

19 wrz 2024, 22:13 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

19 wrz 2024, 22:06 UTC

Earnings

FedEx Stock Is Down. Earnings Show Why The Fed Cut Rates. -- Barrons.com

19 wrz 2024, 21:46 UTC

Top News
Earnings

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue -- Update

19 wrz 2024, 21:06 UTC

Earnings

FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com

19 wrz 2024, 20:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

19 wrz 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19 wrz 2024, 20:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

19 wrz 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19 wrz 2024, 20:42 UTC

Earnings

FedEx Stock Skids, Set To Snap Support As Q1 Results Disappoint -- IBD

19 wrz 2024, 20:39 UTC

Top News

Dow, S&P 500 Hit Records After Rate Cut -- WSJ

19 wrz 2024, 20:12 UTC

Earnings

FedEx Unable to Provide FY25 EPS or Effective Tax Rate Outlook on GAAP Basis >FDX

19 wrz 2024, 20:12 UTC

Earnings

FedEx Cash On-Hand as of Aug 31 Was $5.9 B >FDX

19 wrz 2024, 20:11 UTC

Earnings

FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com

19 wrz 2024, 20:11 UTC

Earnings

FedEx: 'Committed to Our Plan to Return $3.8 B to Stockholders This Fiscal Yr' >FDX

19 wrz 2024, 20:11 UTC

Earnings

FedEx Expects Recent Pricing Actions to Help Offset Weaker-Than-Expected Demand Trends >FDX

19 wrz 2024, 20:10 UTC

Top News

Dow Crosses 42000, Hits Record in Post-Fed Rally -- WSJ

19 wrz 2024, 20:10 UTC

Earnings

FedEx Reaffirms FY25 Capital Spending of $5.2 B >FDX

19 wrz 2024, 20:10 UTC

Earnings

FedEx Reaffirms Permanent Cost Reductions From DRIVE Transformation Program of $2.2 B >FDX

19 wrz 2024, 20:10 UTC

Earnings

FedEx Had Previously Forecast of Low-To-Mid Single Digit Percentage Increase in Rev for FY25>FDX

19 wrz 2024, 20:09 UTC

Earnings

FedEx Sees Low Single-Digit Percentage Rev Growth Rate Yr Over Yr for FY25>FDX

19 wrz 2024, 20:09 UTC

Earnings

FedEx Sees FY25 EPS $20 to $21 After Also Excluding Costs Related to Business Optimization Initiatives >FDX

Peer Comparison

Price change

Amicus Therapeutics Inc Forecast

Price Target

By TipRanks

67.64% upside

12 Months Forecast

Average 18.29 USD  67.64%

High 20 USD

Low 16 USD

Based on 8 Wall Street analysts offering 12 month price targets forAmicus Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

N/A / 11.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

122 / 366 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average